SAN FRANCISCO, July 24, 2017 /PRNewswire/ -- Invitae
Corporation (NYSE: NVTA), one of the fastest growing genetic
information companies, today announced that it will report its
second quarter 2017 financial results on Monday, August 7, 2017 and will host a conference
call that day at 4:30 p.m. Eastern /
1:30 p.m. Pacific to discuss its
financial results and recent developments.
The dial-in numbers for the conference call are (844) 579-6824
for domestic callers and (763) 488-9145 for international callers,
and the reservation number for both is 53628132. Following prepared
remarks, management will respond to questions from investors and
analysts, subject to time limitations. We encourage our
shareholders and those representing them to send in questions to
ir@invitae.com. E-mail questions will be accepted until
4:00 p.m. Eastern / 1:00 p.m. Pacific on Monday, August 7, 2017.
The live webinar of the call may be accessed by visiting the
investors section of the company's website at ir.invitae.com. A
replay of the webinar will be available shortly after the
conclusion of the call and will be archived on the company's
website.
About Invitae
Invitae Corporation (NYSE: NVTA) is one
of the fastest growing genetic information companies in the U.S.
Invitae's mission is to bring comprehensive genetic information
into mainstream medical practice to improve the quality of
healthcare for billions of people. Invitae's goal is to aggregate
most of the world's genetic tests into a single service with higher
quality, faster turnaround time, and lower price than many
single-gene and panel tests today. The company currently provides a
diagnostic service comprising approximately 1,500 genes for a
variety of genetic disorders associated with oncology, cardiology,
neurology, pediatrics, and other rare disease areas, as well as
clinical analysis of a 20,000-gene medical exome. Additionally, the
company has created a Genome Network to connect patients,
clinicians, advocacy organizations, researchers, and therapeutic
developers to accelerate the understanding, diagnosis, and
treatment of hereditary disease. For more information, visit our
website at invitae.com.
Contact:
Kate McNeil
ir@invitae.com
347-204-4226
View original content with
multimedia:http://www.prnewswire.com/news-releases/invitae-to-announce-second-quarter-2017-financial-results-and-host-conference-call-on-august-7-2017-300492644.html
SOURCE Invitae Corporation